# Evaluation of the OtoBand in Subjects With Self-reported Vertigo to Reduce Severity of Vertigo in a Real-world Setting

> **NCT04869020** · NA · COMPLETED · sponsor: **Otolith Labs** · enrollment: 40 (actual)

## Conditions studied

- Vertigo

## Interventions

- **DEVICE:** Otoband
- **DEVICE:** Sham A
- **DEVICE:** Sham B

## Key facts

- **NCT ID:** NCT04869020
- **Lead sponsor:** Otolith Labs
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-19
- **Primary completion:** 2021-12-27
- **Final completion:** 2022-11-26
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04869020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04869020, "Evaluation of the OtoBand in Subjects With Self-reported Vertigo to Reduce Severity of Vertigo in a Real-world Setting". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04869020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*